He will not take any future vaccines using mRNA technology and calls for a ban
For seven years founder and CEO of Canadian genetic consulting company Merogenomics, Dr....
Four years ago in 2022 a paper appeared in the journal Science Translational Medicine entitled “SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies”. It purported to show that Covid vaccine types...
Four years ago in 2022 a paper appeared in the journal Science Translational Medicine entitled “SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies”. It purported to show that...
A peer-reviewed paper published in Environmental Health Perspectives, a top journal from the American Chemical Society, on 23 September 2026 is entitled “Guiding Risk Reduction...